An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors

Marc Ychou, Thierry Conroy, Jean‐François Seitz, Sophie Gourgou, A. Hua, D. Méry-Mignard, A. Kramar

Annals of Oncology · 2003 · 113 citations · 29 references

Concepts

References

29